Role of repeated biopsy of the prostate in predicting disease progression in patients with prostate cancer on active surveillance-Reference-Cited by-同舟云学术

Role of repeated biopsy of the prostate in predicting disease progression in patients with prostate cancer on active surveillance

Published:2008-07-15 Issue:2 Volume:113 Page:286-292
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Al Otaibi Mohammed,Ross Philip,Fahmy Nader,Jeyaganth Suganthiny,Trottier Helen,Sircar Kanishka,Bégin Louis R.,Souhami Luis,Kassouf Wassim,Aprikian Armen,Tanguay Simon

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.23575/fullpdf

Reference25 articles.

1. Screening for prostate cancer: estimating the magnitude of overdetection;McGregor;CMAJ,1998

2. Overdiagnosis due to prostate‐specific antigen screening: lessons from U.S. prostate cancer incidence trends;Etzioni;J Natl Cancer Inst,2002

3. Improved detection of clinically significant, curable prostate cancer with systematic 12‐core biopsy;Singh;J Urol,2004

4. Latent carcinoma of prostate at autopsy in 7 areas. The International Agency for Research on Cancer, Lyons, France;Breslow;Int J Cancer,1977

5. The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients;Sakr;J Urol,1993

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revolutionizing of bioactive natural products in prostate cancer research and care: Promising discoveries and future directions;Intelligent Pharmacy;2024-07

2. Prediction of upgrade to clinically significant prostate cancer in patients under active surveillance: Performance of a fully automated AI‐algorithm for lesion detection and classification;The Prostate;2023-04-04

3. Association between previous negative biopsies and lower rates of progression during active surveillance for prostate cancer;World Journal of Urology;2022-03-26

4. Systematic Review of Active Surveillance for Clinically Localised Prostate Cancer to Develop Recommendations Regarding Inclusion of Intermediate-risk Disease, Biopsy Characteristics at Inclusion and Monitoring, and Surveillance Repeat Biopsy Strategy;European Urology;2021-12

5. Association of Negative Followup Biopsy and Reclassification during Active Surveillance of Prostate Cancer: A Systematic Review and Meta-Analysis;Journal of Urology;2021-06